Search results
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
4 years ago
Prof Nicolas Van Mieghem & Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) give their analysis of the late-breaking trials from AHA 2019.
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
5 years ago
An analysis of the late-breaking trials from ESC. Summaries include a closer look atFUTURE, CULPRIT SHOCK, ASCEND, ART, MITRA FF and the GLOBAL LEADERS trials- interview with Dr Nicolas van Mieghem.
View more
Author(s):
Rolf Wachter
Added:
4 years ago
Professor Rolf Wachter (Universität Leipzig, Leipzig, DE) diskutiertanpassung von Antikoagulation Therapie für Patienten mit paroxysmalem Vorhofflimmern: Dreijahresergebnisse der randomisierten kontrollierten Find-AF Studie.
Fragen:
1. Können Sie für uns die randomisierte Find-AF Studie zusammenfassen?
2. Was bedeutet eine verlängerte und verbesserte Langzeitüberwachung im Rahmen dieser…
View more
Added:
3 years ago
Can screening patients routinely for atrial fibrillation (AF) before it is diagnosed, help to prevent stroke occurrence by prescribing anticoagulation to those with discovered AF?
Dr Steven Lubitz (Massachusetts General Hospital, Boston, MA, US) discusses the results of the VITAL-AF trial which assessed the effectiveness of screening for undiagnosed atrial fibrillation (AF) using simple,…
View more
Author(s):
Ali Aminian
Added:
2 years ago
Dr Ali Aminian (Cleveland Clinic, US) shares the findings of the SPLENDOR study. The study assessed the association of metabolic surgery with major adverse cardiovascular and liver outcomes in patients with biopsy-proven non-alcoholic steatohepatitis. SPLENDOR reported a treatment modality that is associated with decreased risk of major clinical endpoints in patients with NASH.
Discussion Points…
View more
Author(s):
Michael C Gibson
Added:
5 years ago
Dr C. Michael Gibson (Beth Israel Deaconess Medical Center, Boston, MA, US) discusses Rivaroxaban 2.5 mg BID combined with DAPT for the prevention of death/MI/stroke - a patient level data meta-analysis of the ATLAS-ACS-2 TIMI-51 and the COMMANDER HF trials
Filmed on site at CRT 2019 by Radcliffe Cardiology
Questions:
1. Why did you conduct this analysis?
2. How was data collected and…
View more
Author(s):
Horst Sievert
Added:
6 years ago
In this video, Dr Horst Sievert discusses his anticoagulant regime for PFO.
View more
Author(s):
Mirvat Alasnag
,
Added:
3 years ago
Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, Jeddah, KSA) and Dr Connie N Hess (University of Colorado School of Medicine, Aurora, CO, US) discuss the results of the sub-analysis of the VOYAGER PAD Study.
The VOYAGER PAD trial showed that rivaroxaban/aspirin was superior to aspirin at preventing major adverse limb and cardiovascular events.
Dr Hess describes the design of the secondary…
View more
Christopher P Cannon
Research Area(s) / Expertise:
Job title: Professor
Author
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
2 years ago
In this concise episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their analysis of the late-breaking trials that will be presented at ACC 2022.
Trials covered in detail include:
00:39: PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients…
View more